Posted by Michael Wonder on 10 May 2023
Recommendations made out-of-session by the PBAC between March 2023 and July 2023 meetings
10 May 2023 - Recommendations made out-of-session by the PBAC between its March 2023 and July 2023 meetings are now available.
There is only one outcome; a recommendation for buprenorphine and buprenorphine hydrochloride with naloxone hydrochloride for patients with opioid dependence.
